INHALE-1 is a research study that aims to look at how safe an inhaled insulin product is and how well it works in children and teenagers with diabetes.

WHAT’S INVOLVED?

  • The study involves clinic visits, blood draws, and lung function tests
  • Qualified participants will either take inhaled insulin for 12 months or continue mealtime injectable insulin for 6 months and then switch to inhaled insulin for 6 months
  • Inhaled insulin will be provided at no cost
  • Participants will be asked to check their glucose level frequently using a study provided continuous glucose monitor (CGM)

Compensation will be available and a CGM will be provided throughout the study.

WHO CAN JOIN?

  • Children and teenagers between ages 4-17
  • Diagnosed with type 1 or type 2 diabetes and using mealtime insulin (vial or pen, no pumps)
  • A1c is 7-11%
  • No recent history of asthma (in the last 12 months) or other lung conditions
  • No history of smoking (cigarettes, marijuana, or vape) within the last 6 months

If you are interested in learning more, please answer the following questions to see if your child is eligible.

“*” indicates required fields

Please enter a number from 4 to 17.
* You must answer ‘yes’ to move on to the next question.
* You must answer ‘yes’ to move on to the next question.
* You must answer ‘yes’ to move on to the next question.
* You must answer ‘yes’ or ‘unknown’ to move on to the next question.
* You must answer ‘no’ to move on to the next question.

Based on your responses, your child is potentially eligible to participate in this study. To learn more, please visit: https://www.clinicaltrials.gov/study/NCT04974528?term=inhale-1&rank=1

Please enter your contact information below if you would like someone from the INHALE-1 study team to contact you with more information.

Consent*